"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 5 | 5 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 5 | 5 |
| 2002 | 0 | 6 | 6 |
| 2003 | 0 | 6 | 6 |
| 2004 | 0 | 9 | 9 |
| 2005 | 0 | 14 | 14 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 17 | 17 |
| 2008 | 0 | 12 | 12 |
| 2009 | 0 | 29 | 29 |
| 2010 | 0 | 20 | 20 |
| 2011 | 0 | 27 | 27 |
| 2012 | 0 | 27 | 27 |
| 2013 | 1 | 33 | 34 |
| 2014 | 0 | 38 | 38 |
| 2015 | 0 | 44 | 44 |
| 2016 | 0 | 43 | 43 |
| 2017 | 2 | 46 | 48 |
| 2018 | 0 | 46 | 46 |
| 2019 | 0 | 46 | 46 |
| 2020 | 0 | 50 | 50 |
| 2021 | 0 | 39 | 39 |
| 2022 | 0 | 19 | 19 |
| 2023 | 1 | 6 | 7 |
| 2024 | 0 | 11 | 11 |
| 2025 | 0 | 11 | 11 |
| 2026 | 0 | 10 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients. Cancer. 2026 Nov 01; 132(21).
-
Blood-based biomarkers in patients with recurrent, persistent, or metastatic endometrial cancer treated with olaparib and cediranib: Results from NRG-GY012. Cancer. 2026 Oct 15; 132(20):e70649.
-
Tobacco-Associated Dysregulation in TAP-1 and TAP-2 Expression in Oral Premalignant Lesions and Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev. 2026 Oct 01; 27(10):3747-3754.
-
Improbable healing in endodontics: a case series of favorable outcomes despite adverse prognostic conditions. BMC Oral Health. 2026 09 18; 26(1).
-
Precision post-translational modification of PML defines neuroblastoma clinical behaviour. Clin Transl Med. 2026 08; 16(8):e70763.
-
WHO grade 3 pediatric meningioma: a systematic review of clinical features and patient-level analysis of prognostic factors. Childs Nerv Syst. 2026 Jul 14; 42(1).
-
Treatment Decision-Making Roles and Preferences Among Adolescents and Young Adults With Cancer. Pediatr Blood Cancer. 2026 Jun; 73(6):e70235.
-
Atrial fibrillation/flutter at presentation is associated with worse functional outcome in acute ischemic stroke patients treated with thrombolytic therapy: A multicenter retrospective cohort study. Clin Neurol Neurosurg. 2026 Jul; 266:109392.
-
Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response. Acta Neuropathol. 2026 Mar 02; 151(1).
-
NF-?B (p65, p50), IL-18, and IL-10 as Therapeutic Targets in Prostate Cancer and BPH: Molecular Insights into Inflammation-Driven Pathogenesis. Asian Pac J Cancer Prev. 2026 Jan 01; 27(1):381-388.